| Continued improved wear with an annealed highly cross-linked polyethylene. | |
| | |
MedLine Citation:
|
PMID: 20844996 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Highly cross-linked polyethylene (HXLPE), created by disrupting the molecular structure of polyethylene, then through the application of heat, encourages creation of new cross-links in the process, resulting in a material with improved wear resistance. The impetuses for this new technology were the unsatisfactory wear properties and subsequent osteolysis of noncross-linked polyethylene. A 72% reduction in wear using highly cross-linked polyethylenes (HXLPE) compared with conventional polyethylene at 5 years was described previously. The longest term followup studies on HXLPE range from 2 to 6 years. QUESTIONS/PURPOSES: We therefore addressed the following questions: (1) Does the improvement in wear observed at the earlier followup continue to 7 to 10 years? (2) What is the incidence of osteolysis in this group of patients and in the control group? METHODS: We retrospectively reviewed 38 prospectively followed patients who had 42 hips with an annealed HXLPE who were followed a minimum of 7 years (average, 8.6 years; SD=1; range, 7-10.3 years). Wear and osteolysis were compared with those of a control group of 39 patients (40 hips) from a US Investigational Device Exemption (IDE) prospective, randomized study begun in 1996 with conventional polyethylene and followed for a minimum of 6 years (average, 7.5 years; SD=1.1; range, 6-10.2 years). Linear head penetration was measured from AP radiographs at early, 1-year, 5-year, and most recent followups. RESULTS: At the average followup, annual linear wear was 0.031 mm (SD=0.014) for the HXLPE and 0.141 mm (SD=0.080) for the control group, a 78% reduction. No mechanical failure of the polyethylene was noted in either group. Incidence of osteolysis was 50% in the control group (all lesions confined to proximal Gruen Zones 1 and 7) compared with no cases in the investigational group. CONCLUSIONS: We observed an improvement in wear and no mechanical failures with this annealed material. LEVEL OF EVIDENCE: Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence. |
| | |
Authors:
|
William N Capello; James A D'Antonio; Rama Ramakrishnan; Marybeth Naughton |
Related Documents
:
|
19056226 - Tibial fixation without screws in cementless knee arthroplasty. 10037336 - Migration of the uncemented cls acetabular component. 10335296 - Pelvic reconstruction for severe periacetabular metastatic disease. 8521336 - Ilizarov femoral lengthening in adults. 22971306 - Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecut... 10508806 - Bronchopulmonary segmental lavage with surfaxin (kl(4)-surfactant) for acute respirator... |
Publication Detail:
|
Type: Comparative Study; Journal Article Date: 2010-09-16 |
Journal Detail:
|
Title: Clinical orthopaedics and related research Volume: 469 ISSN: 1528-1132 ISO Abbreviation: Clin. Orthop. Relat. Res. Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-02-03 Completed Date: 2011-03-24 Revised Date: 2013-05-27 |
Medline Journal Info:
|
Nlm Unique ID: 0075674 Medline TA: Clin Orthop Relat Res Country: United States |
Other Details:
|
Languages: eng Pagination: 825-30 Citation Subset: AIM; IM |
Affiliation:
|
Indiana University School of Medicine, 541 Clinical Drive, Suite 600, Indianapolis, IN 46202, USA. wcapello@iupui.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Arthroplasty, Replacement, Hip
/
instrumentation*,
methods Cross-Linking Reagents Equipment Failure Analysis Female Femur Head / radiography Hip Prosthesis* Humans Incidence Indiana / epidemiology Male Middle Aged Osteolysis / epidemiology, etiology* Polyethylenes* / chemistry Prosthesis Design Prosthesis Failure / adverse effects* Randomized Controlled Trials as Topic Retrospective Studies Surface Properties |
| Chemical | |
Reg. No./Substance:
|
0/Cross-Linking Reagents; 0/Polyethylenes |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission,...
Next Document: Hip offset in total hip arthroplasty: quantitative measurement with navigation.